These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25482255)

  • 41. Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
    Birnbaum G; Cree B; Altafullah I; Zinser M; Reder AT
    Neurology; 2008 Oct; 71(18):1390-5. PubMed ID: 18525027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study.
    Saida T; Tashiro K; Itoyama Y; Sato T; Ohashi Y; Zhao Z;
    Neurology; 2005 Feb; 64(4):621-30. PubMed ID: 15728282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Logistics and description of treatment technology (the protocol for using disease modifying drugs--DMD)].
    Federal service on surveillance in healthcare and social development (Roszdravnadzor)
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):93-8. PubMed ID: 21916163
    [No Abstract]   [Full Text] [Related]  

  • 44. MxA mRNA expression as a biomarker of interferon beta response in multiple sclerosis patients.
    Matas E; Bau L; Martínez-Iniesta M; Romero-Pinel L; Mañé-Martínez MA; Cobo-Calvo Á; Martínez-Yélamos S
    J Neuroimmunol; 2016 Feb; 291():73-7. PubMed ID: 26857498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interferon treatment for multiple sclerosis patients in Hong Kong.
    Lau KK; Lee PO; Chan KY; Chan YW; Chin KF
    Hong Kong Med J; 2000 Jun; 6(2):221-3. PubMed ID: 10895148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta-interferon for multiple sclerosis.
    Rudick RA; Goelz SE
    Exp Cell Res; 2011 May; 317(9):1301-11. PubMed ID: 21396360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Neuroprotective effect of the long-term beta-interferon course in multiple sclerosis: direct and indirect mechanisms].
    Gusev EI; Boĭko AN; Khachanova NV; Demina TL; Davydovskaia MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):70-3. PubMed ID: 16841488
    [No Abstract]   [Full Text] [Related]  

  • 48. PEGylated interferon beta-1a: meeting an unmet medical need in the treatment of relapsing multiple sclerosis.
    Baker DP; Pepinsky RB; Brickelmaier M; Gronke RS; Hu X; Olivier K; Lerner M; Miller L; Crossman M; Nestorov I; Subramanyam M; Hitchman S; Glick G; Richman S; Liu S; Zhu Y; Panzara MA; Davar G
    J Interferon Cytokine Res; 2010 Oct; 30(10):777-85. PubMed ID: 20836711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Results of a comparative clinical trial of the Russian Β - interferon-1b bioanalogue (infibeta)].
    Popova EV; Boĭko AN; Vasil'ev AV; Davydovskaia MV; Zavalishin IA; Kotov SV; Krotenkova MV; Khachanova NV; Sharanova SN; Shchur SG; Iakushina TI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5):56-61. PubMed ID: 22951783
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature.
    Gaetani L; Menduno PS; Cometa F; Di Gregorio M; Sarchielli P; Cagini C; Calabresi P; Di Filippo M
    J Neurol; 2016 Mar; 263(3):422-7. PubMed ID: 26292794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The UK Risk-Sharing Scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis.
    Duddy M; Palace J
    Pract Neurol; 2016 Feb; 16(1):4-6. PubMed ID: 26430247
    [No Abstract]   [Full Text] [Related]  

  • 52. [Interferon β].
    Matsushita T
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():196-204. PubMed ID: 26480700
    [No Abstract]   [Full Text] [Related]  

  • 53. Bioavailability of interferon-beta in patients with multiple sclerosis - fishing for the surrogate.
    Kieseier BC; Hartung HP
    Eur J Neurol; 2010 Mar; 17(3):344-5. PubMed ID: 20050905
    [No Abstract]   [Full Text] [Related]  

  • 54. Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients.
    Koudriavtseva T; Plantone D; Renna R; Mandoj C; Giannarelli D; Mainero C
    Neurol Sci; 2015 Dec; 36(12):2263-8. PubMed ID: 26209931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients.
    Malhotra S; Sorosina M; Río J; Peroni S; Midaglia L; Villar LM; Álvarez-Cermeño JC; Schroeder I; Esposito F; Clarelli F; Zettl UK; Lechner-Scott J; Spataro N; Navarro A; Comi G; Montalban X; Martinelli-Boneschi F; Comabella M
    Mult Scler; 2018 Oct; 24(11):1507-1510. PubMed ID: 29117789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interferon-beta in multiple sclerosis. Can we control its costs?
    Madgwick T
    Pharmacoeconomics; 1997 Oct; 12(4):499-501. PubMed ID: 10174315
    [No Abstract]   [Full Text] [Related]  

  • 57. Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statins.
    Feng X; Han D; Kilaru BK; Franek BS; Niewold TB; Reder AT
    Arch Neurol; 2012 Oct; 69(10):1303-9. PubMed ID: 22801747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutralizing antibodies in interferon beta treated patients with multiple sclerosis: knowing what to do now : Commentary to: 10.1007/s00415-010-5844-5 "One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients" by S. Malucchi et al.
    Menge T; Hartung HP; Kieseier BC
    J Neurol; 2011 May; 258(5):904-7. PubMed ID: 21340521
    [No Abstract]   [Full Text] [Related]  

  • 59. Ibuprofen treatment versus gradual introduction of interferon beta-1b in patients with MS.
    Rice GP; Ebers GC; Lublin FD; Knobler RL
    Neurology; 1999 Jun; 52(9):1893-5. PubMed ID: 10371541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Managing the adverse effects of interferon-beta therapy in multiple sclerosis.
    Bayas A; Rieckmann P
    Drug Saf; 2000 Feb; 22(2):149-59. PubMed ID: 10672896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.